Skip to main content
Clinical Trials/IRCT2015042114333N32
IRCT2015042114333N32
Completed
Phase 2

Comparating the effect of combination and single therapy of exjade and desferal on ferritin level in patients with major thalassemia

Kermanshahu University of Medical Sciences0 sites90 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Major Thalassemia.
Sponsor
Kermanshahu University of Medical Sciences
Enrollment
90
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Kermanshahu University of Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • Inclusion: being younger than 18; having thalasemia major based on observing clinical symptoms and hemoglobin electrophoresis history; being treated by deferoxamine hypodermic injection and ferritin level 1000 to 3000\. Exclusion:inability to digest exjade; hepatitis virologic; LFT; active hepatitis; noncompliance with previous treatment regimens; ALT and AST normal up to 3 times

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials